IL235615A0 - Salmonella typhi ty21a expressing f1-v yersinia pestis fusion protein and uses thereof - Google Patents

Salmonella typhi ty21a expressing f1-v yersinia pestis fusion protein and uses thereof

Info

Publication number
IL235615A0
IL235615A0 IL235615A IL23561514A IL235615A0 IL 235615 A0 IL235615 A0 IL 235615A0 IL 235615 A IL235615 A IL 235615A IL 23561514 A IL23561514 A IL 23561514A IL 235615 A0 IL235615 A0 IL 235615A0
Authority
IL
Israel
Prior art keywords
fusion protein
salmonella typhi
yersinia pestis
typhi ty21a
ty21a expressing
Prior art date
Application number
IL235615A
Other languages
English (en)
Hebrew (he)
Original Assignee
Us Sec Dep Of Health & Human Services
Dennis J Kopecko
Manuel Osorio
Monica R Foote
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Us Sec Dep Of Health & Human Services, Dennis J Kopecko, Manuel Osorio, Monica R Foote filed Critical Us Sec Dep Of Health & Human Services
Publication of IL235615A0 publication Critical patent/IL235615A0/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A61K39/0291—Yersinia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/523—Bacterial cells; Fungal cells; Protozoal cells expressing foreign proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/036—Fusion polypeptide containing a localisation/targetting motif targeting to the medium outside of the cell, e.g. type III secretion
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
IL235615A 2012-05-23 2014-11-10 Salmonella typhi ty21a expressing f1-v yersinia pestis fusion protein and uses thereof IL235615A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261650676P 2012-05-23 2012-05-23
PCT/US2013/042240 WO2013177291A1 (en) 2012-05-23 2013-05-22 Salmonella typhi ty21a expressing yersinia pestis f1-v fusion protein and uses thereof

Publications (1)

Publication Number Publication Date
IL235615A0 true IL235615A0 (en) 2015-01-29

Family

ID=48539444

Family Applications (1)

Application Number Title Priority Date Filing Date
IL235615A IL235615A0 (en) 2012-05-23 2014-11-10 Salmonella typhi ty21a expressing f1-v yersinia pestis fusion protein and uses thereof

Country Status (7)

Country Link
US (1) US9409956B2 (https=)
EP (1) EP2852405B1 (https=)
JP (1) JP6216371B2 (https=)
CN (1) CN104470537B (https=)
IL (1) IL235615A0 (https=)
IN (1) IN2014DN09618A (https=)
WO (1) WO2013177291A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10806778B2 (en) * 2019-01-30 2020-10-20 Prokarium Limited Modified strain of Salmonella enterica Typhi

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3856935A (en) 1971-04-29 1974-12-24 Schweiz Serum & Impfinst Oral typhoid vaccine and method of preparing the same
GB9326425D0 (en) 1993-12-24 1994-02-23 Secr Defence Vaccine compositions
US6429199B1 (en) 1994-07-15 2002-08-06 University Of Iowa Research Foundation Immunostimulatory nucleic acid molecules for activating dendritic cells
US6207646B1 (en) 1994-07-15 2001-03-27 University Of Iowa Research Foundation Immunostimulatory nucleic acid molecules
US6239116B1 (en) 1994-07-15 2001-05-29 University Of Iowa Research Foundation Immunostimulatory nucleic acid molecules
ATE509102T1 (de) 1994-07-15 2011-05-15 Univ Iowa Res Found Immunomodulatorische oligonukleotide
CA2215203C (en) * 1995-03-13 2008-12-09 The Secretary Of State For Defence In Her Britannic Majesty's Government Of The United Kingdom Of Great Britain And Northern Ireland Vaccines for plague
WO1998037919A1 (en) 1997-02-28 1998-09-03 University Of Iowa Research Foundation USE OF NUCLEIC ACIDS CONTAINING UNMETHYLATED CpG DINUCLEOTIDE IN THE TREATMENT OF LPS-ASSOCIATED DISORDERS
US6406705B1 (en) 1997-03-10 2002-06-18 University Of Iowa Research Foundation Use of nucleic acids containing unmethylated CpG dinucleotide as an adjuvant
AU7690898A (en) 1997-05-20 1998-12-11 Ottawa Civic Hospital Loeb Research Institute Vectors and methods for immunization or therapeutic protocols
ATE356630T1 (de) 1998-04-03 2007-04-15 Univ Iowa Res Found Verfahren und produkte zur stimulierung des immunsystems mittels immunotherapeutischer oligonukleotide und zytokine
PT1108034E (pt) * 1998-09-04 2008-11-14 Emergent Product Dev Uk Ltd Mutantes de spi2 de salmonela atenuados como transportadores de antigénios
GB9921275D0 (en) * 1999-09-10 1999-11-10 Secr Defence Recombinant microorganisms
EP1670505B1 (en) * 2003-09-18 2012-11-14 GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES Dna promoters and anthrax vaccines
WO2005056769A2 (en) * 2003-12-09 2005-06-23 Avant Immunotherapeutics, Inc. Orally-administered live bacterial vaccines for plague
US20080124355A1 (en) * 2006-09-22 2008-05-29 David Gordon Bermudes Live bacterial vaccines for viral infection prophylaxis or treatment
EP1921149A1 (en) * 2006-11-13 2008-05-14 AEterna Zentaris GmbH Microorganisms as carriers of nucleotide sequences coding for antigens and protein toxins, process of manufacturing and uses thereof

Also Published As

Publication number Publication date
US20150152144A1 (en) 2015-06-04
EP2852405A1 (en) 2015-04-01
EP2852405B1 (en) 2019-03-13
JP2015519061A (ja) 2015-07-09
IN2014DN09618A (https=) 2015-07-31
CN104470537B (zh) 2017-04-26
JP6216371B2 (ja) 2017-10-18
CN104470537A (zh) 2015-03-25
WO2013177291A1 (en) 2013-11-28
US9409956B2 (en) 2016-08-09
WO2013177291A8 (en) 2014-12-24

Similar Documents

Publication Publication Date Title
PL3310805T3 (pl) Białka fuzyjne pd-1-cd28 i ich zastosowanie w medycynie
IL236809A0 (en) Interleukin-10 fusion proteins and their use
ZA201507104B (en) Novel insulin analog and use thereof
IL240034A0 (en) Chimeric proteins based on l1–pd and –pd–l2 and their uses
ZA201601430B (en) Insecticidal proteins and methods for their use
ZA201509369B (en) Insecticidal proteins and methods for their use
GB201509062D0 (en) OX40L fusion proteins and uses thereof
IL236933A0 (en) Interleukin-2 fusion proteins and their use
IL229753A0 (en) Proteins that release relaxin and their use
DK3321287T3 (da) Fusionsproteiner og kombinationsvacciner
SI3063275T1 (sl) Terapevtske fuzije nukleaza-albumin in postopki
IL243576A0 (en) Image fusion methods for mri and their use
ZA201600086B (en) Therapeutic fusion protein
PL2895512T3 (pl) Przeciwciała swoiste dla polipeptydu amyloidowego ludzkich wysepek (HIAPP) i ich zastosowania
EP3029072A4 (en) Glp-1 analog fusion protein and preparation method and use thereof
GB201412517D0 (en) Composite light harvesting material and device
DK3173102T3 (da) FGFR-FC-fusionsprotein og anvendelse deraf
PL2983704T4 (pl) Polipeptydy i szczepionki fuzyjne
EP2969009A4 (en) MODIFIED FC FUSION PROTEINS
EP2990010A4 (en) ARTIFICIAL BLOOD VESSEL
SG10201701866QA (en) Ube2t peptides and vaccines containing the same
EP2816049B8 (de) ß-Ketophosphonsäuren und Dentalmateriallen auf deren Basis
GB201514049D0 (en) Polyethylene terephthelate part bonded to polyester and polycarbonate alloy part
IL235615A0 (en) Salmonella typhi ty21a expressing f1-v yersinia pestis fusion protein and uses thereof
PL2976093T3 (pl) Bakteriofagi przeciwko salmonella SSP i ich zastosowanie